Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mary Thistle currently holds 25,743 shares of ZIOPHARM ONCOLOGY INC (ZIOP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mary Thistle has been a net neutral trader of ZIOP stock. They have purchased $0 and sold $0 worth of shares.
Mary Thistle's most recent insider trade was on Aug 5, 2025, when they sold 5,000 shares at $0.00 per share.
Mary Thistle serves as Executive at ZIOPHARM ONCOLOGY INC (ZIOP). They have executed 14 insider transactions totaling $0 over their tenure at the company.
Mary Thistle holds the position of Executive at ZIOPHARM ONCOLOGY INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Mary Thistle has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Mary Thistle was on Aug 5, 2025, when they sold $0 worth of VIGL shares. This transaction involved 5,000 shares at N/A per share.
Mary Thistle currently owns 25,743 shares of ZIOPHARM ONCOLOGY INC (ZIOP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mary Thistle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mary Thistle has 14 Form 4 filings on record as an insider at ZIOPHARM ONCOLOGY INC.
Set alerts for Mary Thistle and 40,000+ other insiders.